India's drug regulatory body, CDSCO, has banned 35 fixed-dose combination drugs, including painkillers and anti-diabetics, ...

Prime Biome is uniquely formulated by recognizing the connection between the skin and the gut and targeting both in o ...

In the world of wellness and dietary supplements, the focus on natural and effective solutions for weight management and overall health has never been greater. One intriguing product that has emerged ...

In an era where health and wellness are paramount, the demand for effective supplements has surged. InsuFend emerges as a notable contender in this realm, explicitly designed for individuals seeking ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Evotec is particularly focused on expanding its biologics capabilities to meet increased demand for complex biologics manufacturing and broaden its offerings to customers. We expect the company will ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a type 2 diabetes application ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Lilly said its investigational once-daily pill achieved positive topline results in a late-stage study evaluating the safety and efficacy of orforglipron compared with a placebo in adults with type 2 ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...